Clot waveform analysis in patients with haemophilia A

被引:26
|
作者
Siegemund, T. [1 ]
Scholz, U. [2 ]
Schobess, R. [2 ]
Siegemund, A. [2 ]
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, Roon Res Ctr Arteriosclerosis & Thrombosis, La Jolla, CA 92037 USA
[2] Ctr Coagulat Disorders, MVZ Lab Dr Reising Ackermann & Colleagues, D-04289 Leipzig, Germany
来源
HAMOSTASEOLOGIE | 2014年 / 34卷 / 4A期
关键词
Activated partial thromboplastin time; fibrin formation kinetics; thrombin; prothrombinase; tenase; haemophilia; PARTIAL THROMBOPLASTIN TIME; COAGULATION; FIBRIN; BLOOD; MODEL;
D O I
10.5482/HAMO-14-02-0016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clot waveform analysis extends the interpretation of aPTT measurement curves. The curve is mathematically processed to obtain information about fibrin formation kinetics including semiquantitative determination of thrombin, prothrombinase and tenase activity. Patients, method: In this study the feasibility of clot waveform analysis for monitoring of haemophilia A was investigated using blood samples from healthy controls as well as haemophilia A patients under various clinical conditions. Results: Thrombin, prothrombinase and tenase activity show a high correlation to factor VIII levels. Tenase activity was found to exhibit a linear relationship to factor VIII levels over a very large concentration range and was able to discriminate patients with severe, moderate and mild haemophilia. Conclusion: Clot waveform analysis is an easy, fast and cheap method to access disturbances in clot formation and can be done without any additional measurements beside an aPTT.
引用
收藏
页码:S48 / S52
页数:5
相关论文
共 50 条
  • [21] Towards standardization of clot waveform analysis and recommendations for its clinical applications
    Shima, M.
    Thachil, J.
    Nair, S. C.
    Srivastava, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (07) : 1417 - 1420
  • [22] Effects of Hemodilution on Clot Waveform Analysis Parameters, Clotting Factors, and Thrombin Generation Assays in a Dilutional Model Based on Analysis of 11 Healthy Male Blood Donors
    Ichikawa, Junko
    Okazaki, Ryouta
    Fukuda, Tomoki
    Yoon, Daejoon
    Komori, Makiko
    MEDICAL SCIENCE MONITOR, 2022, 28
  • [23] Diagnostic analysis of lupus anticoagulant using clot waveform analysis in activated partial thromboplastin time prolonged cases: A retrospective analysis
    Kanouchi, Kazunori
    Narimatsu, Hiroto
    Shirata, Toru
    Morikane, Keita
    HEALTH SCIENCE REPORTS, 2021, 4 (02)
  • [24] Reagent Effects on the Activated Partial Thromboplastin Time Clot Waveform Analysis: A Multi-Centre Study
    Wong, Wan Hui
    Tan, Chuen Wen
    Abdul Khalid, Nabeelah Binti
    Dalimoenthe, Nadjwa Zamalek
    Yip, Christina
    Tantanate, Chaicharoen
    Lim, Rodelio D.
    Kim, Ji Hyun
    Ng, Heng Joo
    DIAGNOSTICS, 2023, 13 (14)
  • [25] Clot waveform analysis in Clauss fibrinogen assay contributes to classification of fibrinogen disorders
    Suzuki, Atsuo
    Suzuki, Nobuaki
    Kanematsu, Takeshi
    Shinohara, Sho
    Arai, Nobuo
    Kikuchi, Ryosuke
    Matsushita, Tadashi
    THROMBOSIS RESEARCH, 2019, 174 : 98 - 103
  • [26] Clot waveform analysis of prolonged activated partial thromboplastin time in various disorders
    Kadu, Apeksha
    Shah, Ami M.
    Goswami, Hansa
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2025, 68 (01) : 137 - 140
  • [27] Screening method for congenital dysfibrinogenemia using clot waveform analysis with the Clauss method
    Arai, Shinpei
    Kamijo, Tomu
    Hayashi, Fumiaki
    Shinohara, Sho
    Arai, Nobuo
    Sugano, Mitsutoshi
    Uehara, Takeshi
    Honda, Takayuki
    Okumura, Nobuo
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (02) : 281 - 289
  • [28] Clot lysis phenotype and response to recombinant factor VIIa in plasma of haemophilia A inhibitor patients
    Bakhtiari, Kamran
    Kamphuisen, Pieter W.
    Mancuso, Maria E.
    Hamulyak, Karly
    Schutgens, Roger E. G.
    Santagostino, Elena
    Meijers, Joost C. M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (06) : 827 - 835
  • [29] Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitorsphase I trial: 2nd report
    Shirahata, A.
    Fukutake, K.
    Mimaya, J.
    Takamatsu, J.
    Shima, M.
    Hanabusa, H.
    Takedani, H.
    Takashima, Y.
    Matsushita, T.
    Tawa, A.
    Higasa, S.
    Takata, N.
    Sakai, M.
    Kawakami, K.
    Ohashi, Y.
    Saito, H.
    HAEMOPHILIA, 2013, 19 (02) : 330 - 337
  • [30] High dose factor VIIa improves clot structure and stability in a model of haemophilia B
    Wolberg, AS
    Allen, GA
    Monroe, DM
    Hedner, U
    Roberts, HR
    Hoffman, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (05) : 645 - 655